drugset / Trial / NCT04071756
Topical Tazarotene Vs Placebo In Hand-Foot-Skin Reactions
RandomizedParallel-groupTriple-blindTreatment
Summary
This research is studying the preventative use of topical 0.1% tazarotene gel daily in addition to best practice standards to reduce the development of hand-foot skin reaction (HFSR).
Timeline
- Start
- 2019-12-30
- Primary completion
- 2021-06-12
- Completion
- 2022-07-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tazarotene | Small molecule | 0.1 % | Topical |